Results 221 to 230 of about 8,071,482 (284)

Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics

British Journal of Clinical Pharmacology, EarlyView.
Dyfrig A. Hughes, Henry Fong, Grace Hampson, Catrin O. Plumpton, Chris Sampson   +4 more
wiley   +1 more source

Let's Talk About Myopia: Literature Review and Stakeholder Survey to Develop a Roadmap for Advocacy. [PDF]

J Patient Exp
Dahlmann-Noor A, Noor H.
europepmc   +1 more source

Screening Breast MRI and Genetic Testing Utilization in High-risk Population: Analysis of National Health Interview Survey. [PDF]

J Breast Imaging
Maini I, Gilotra K, Sharifian M, Capiro N, Sadigh G.   +4 more
europepmc   +1 more source

Potential Barriers to Participating in Cancer Moonshot Biobank for Low-Income Patients with Cancer of Rural Maine. [PDF]

Biopreserv Biobank
Kohut M, Saunders J, Korsen N, Breggia A, Prescott J, Remick SC, Miesfeldt S.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Social Insurances and Risky Financial Market Participation: Evidence from China

Emerging markets finance & trade, 2022
Using four-wave national longitudinal survey data, this study estimates the influence of pension and medical insurance on risky financial market participation for individuals aged ≥ 45 years in China. Three key findings emerge.
Xinxin Ma
semanticscholar   +1 more source